NZ739573A - Improved methods for the acylation of maytansinol - Google Patents

Improved methods for the acylation of maytansinol

Info

Publication number
NZ739573A
NZ739573A NZ73957313A NZ73957313A NZ739573A NZ 739573 A NZ739573 A NZ 739573A NZ 73957313 A NZ73957313 A NZ 73957313A NZ 73957313 A NZ73957313 A NZ 73957313A NZ 739573 A NZ739573 A NZ 739573A
Authority
NZ
New Zealand
Prior art keywords
maytansinol
acylation
improved methods
amino acid
reaction
Prior art date
Application number
NZ73957313A
Other languages
English (en)
Inventor
Wayne Widdison
Robert Yongxin Zhao
Original Assignee
Immunogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunogen Inc filed Critical Immunogen Inc
Publication of NZ739573A publication Critical patent/NZ739573A/en

Links

Classifications

    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01R—ELECTRICALLY-CONDUCTIVE CONNECTIONS; STRUCTURAL ASSOCIATIONS OF A PLURALITY OF MUTUALLY-INSULATED ELECTRICAL CONNECTING ELEMENTS; COUPLING DEVICES; CURRENT COLLECTORS
    • H01R12/00—Structural associations of a plurality of mutually-insulated electrical connecting elements, specially adapted for printed circuits, e.g. printed circuit boards [PCB], flat or ribbon cables, or like generally planar structures, e.g. terminal strips, terminal blocks; Coupling devices specially adapted for printed circuits, flat or ribbon cables, or like generally planar structures; Terminals specially adapted for contact with, or insertion into, printed circuits, flat or ribbon cables, or like generally planar structures
    • H01R12/50—Fixed connections
    • H01R12/51—Fixed connections for rigid printed circuits or like structures
    • H01R12/55—Fixed connections for rigid printed circuits or like structures characterised by the terminals
    • H01R12/58—Fixed connections for rigid printed circuits or like structures characterised by the terminals terminals for insertion into holes
    • H01R12/585—Terminals having a press fit or a compliant portion and a shank passing through a hole in the printed circuit board
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/16—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • H—ELECTRICITY
    • H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05K—PRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
    • H05K1/00—Printed circuits
    • H05K1/02—Details
    • H05K1/0201—Thermal arrangements, e.g. for cooling, heating or preventing overheating
    • H05K1/0203—Cooling of mounted components
    • H—ELECTRICITY
    • H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05K—PRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
    • H05K1/00—Printed circuits
    • H05K1/02—Details
    • H05K1/11—Printed elements for providing electric connections to or between printed circuits
    • H05K1/115—Via connections; Lands around holes or via connections
    • H05K1/116—Lands, clearance holes or other lay-out details concerning the surrounding of a via
    • H—ELECTRICITY
    • H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05K—PRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
    • H05K1/00—Printed circuits
    • H05K1/18—Printed circuits structurally associated with non-printed electric components
    • H05K1/181—Printed circuits structurally associated with non-printed electric components associated with surface mounted components

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Microelectronics & Electronic Packaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyamides (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NZ73957313A 2012-09-26 2013-09-26 Improved methods for the acylation of maytansinol NZ739573A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261705731P 2012-09-26 2012-09-26
NZ706019A NZ706019A (en) 2012-09-26 2013-09-26 Improved methods for the acylation of maytansinol

Publications (1)

Publication Number Publication Date
NZ739573A true NZ739573A (en) 2019-11-29

Family

ID=49328648

Family Applications (2)

Application Number Title Priority Date Filing Date
NZ73957313A NZ739573A (en) 2012-09-26 2013-09-26 Improved methods for the acylation of maytansinol
NZ706019A NZ706019A (en) 2012-09-26 2013-09-26 Improved methods for the acylation of maytansinol

Family Applications After (1)

Application Number Title Priority Date Filing Date
NZ706019A NZ706019A (en) 2012-09-26 2013-09-26 Improved methods for the acylation of maytansinol

Country Status (27)

Country Link
US (9) US9012629B2 (enExample)
EP (3) EP3904358A1 (enExample)
JP (7) JP6517693B2 (enExample)
CN (2) CN104768955B (enExample)
AU (4) AU2013323572B2 (enExample)
BR (2) BR112015006505B1 (enExample)
CA (2) CA2884873C (enExample)
CY (2) CY1121415T1 (enExample)
DK (2) DK3486248T3 (enExample)
ES (2) ES2880754T3 (enExample)
HR (2) HRP20190473T1 (enExample)
HU (2) HUE055443T2 (enExample)
IL (2) IL237899A (enExample)
LT (2) LT3486248T (enExample)
MX (2) MX390615B (enExample)
MY (1) MY169250A (enExample)
NZ (2) NZ739573A (enExample)
PL (2) PL2900676T3 (enExample)
PT (2) PT3486248T (enExample)
RS (2) RS62075B1 (enExample)
RU (2) RU2648992C2 (enExample)
SG (1) SG11201501918UA (enExample)
SI (2) SI3486248T1 (enExample)
SM (2) SMT201900170T1 (enExample)
TR (1) TR201903625T4 (enExample)
WO (1) WO2014052537A1 (enExample)
ZA (1) ZA201501898B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SMT201900170T1 (it) * 2012-09-26 2019-05-10 Immunogen Inc Metodo migliorato per l'acilazione di maytansinolo
CN105585579A (zh) * 2014-10-24 2016-05-18 南京联宁生物制药有限公司 一种化合物及其制备方法以及美登素dm1的制备方法
WO2016149464A1 (en) * 2015-03-17 2016-09-22 Regeneron Pharmaceuticals, Inc. Amino acid acylation reagents and methods of using the same
EP3554544A4 (en) 2016-12-16 2020-07-29 Bluefin Biomedicine, Inc. ANTI-PROTEIN 1 ANTIBODY CONTAINING AN ANTI-CUB DOMAIN (CDCP1), ANTIBODY-DRUG CONJUGATES AND THEIR METHODS OF USE
EP3956332B1 (en) 2019-04-18 2023-02-22 Indena S.p.A. Diasteroselective process for the preparation of thiol- or disulfide-containing maytansinoid esters and intermediates thereof
US12473579B2 (en) 2019-11-29 2025-11-18 Microbiopharm Japan Co., Ltd. Method for enzymatically producing maytansinol
EP4685150A1 (en) 2023-04-28 2026-01-28 Chugai Seiyaku Kabushiki Kaisha Method for producing amide group-containing compound using n-carboxyamino acid anhydride

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4151042A (en) 1977-03-31 1979-04-24 Takeda Chemical Industries, Ltd. Method for producing maytansinol and its derivatives
JPS6034556B2 (ja) * 1977-03-31 1985-08-09 武田薬品工業株式会社 抗生物質ｃ−１５００３
US4137230A (en) 1977-11-14 1979-01-30 Takeda Chemical Industries, Ltd. Method for the production of maytansinoids
US4265814A (en) 1978-03-24 1981-05-05 Takeda Chemical Industries Matansinol 3-n-hexadecanoate
JPS5562090A (en) 1978-10-27 1980-05-10 Takeda Chem Ind Ltd Novel maytansinoid compound and its preparation
JPS5566585A (en) 1978-11-14 1980-05-20 Takeda Chem Ind Ltd Novel maytansinoid compound and its preparation
JPS55164687A (en) 1979-06-11 1980-12-22 Takeda Chem Ind Ltd Novel maytansinoid compound and its preparation
JPS55162791A (en) 1979-06-05 1980-12-18 Takeda Chem Ind Ltd Antibiotic c-15003pnd and its preparation
JPS55164685A (en) 1979-06-08 1980-12-22 Takeda Chem Ind Ltd Novel maytansinoid compound and its preparation
JPS55164686A (en) 1979-06-11 1980-12-22 Takeda Chem Ind Ltd Novel maytansinoid compound and its preparation
US4309428A (en) 1979-07-30 1982-01-05 Takeda Chemical Industries, Ltd. Maytansinoids
JPS5622790A (en) * 1979-07-31 1981-03-03 Takeda Chem Ind Ltd Novel maytansinoid compound and its preparation
JPS5645483A (en) 1979-09-19 1981-04-25 Takeda Chem Ind Ltd C-15003phm and its preparation
JP3054741B2 (ja) * 1989-09-29 2000-06-19 武田薬品工業株式会社 Ｔａｎ―１３１３およびそのアシル誘導体
US5208020A (en) 1989-10-25 1993-05-04 Immunogen Inc. Cytotoxic agents comprising maytansinoids and their therapeutic use
JP4776843B2 (ja) * 1999-10-01 2011-09-21 イムノゲン インコーポレーティッド 免疫複合体及び化学療法剤を用いる癌治療用組成物及び方法
US6441163B1 (en) 2001-05-31 2002-08-27 Immunogen, Inc. Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents
TWI298067B (en) * 2002-01-31 2008-06-21 Daiso Co Ltd New optically active compound, method for kinetic resolution of carbonic acid derivatives and catalyst thereof
US8088387B2 (en) 2003-10-10 2012-01-03 Immunogen Inc. Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates
EP1651162B1 (en) * 2003-05-20 2015-10-21 ImmunoGen, Inc. Improved cytotoxic agents comprising new maytansinoids
MXPA06002088A (es) * 2003-08-22 2006-08-11 Activbiotics Inc Analogos de rifamicina y usos de los mismos.
TR201808537T4 (tr) 2004-09-23 2018-07-23 Genentech Inc Sistein değiştirilmiş antikorlar ve konjugatlar.
KR101281501B1 (ko) 2004-12-09 2013-07-15 얀센 바이오테크 인코포레이티드 항인테그린 면역 컨쥬게이트, 방법 및 용도
US7301019B2 (en) * 2005-01-21 2007-11-27 Immunogen, Inc. Method for the preparation of maytansinoid esters
WO2007011721A1 (en) * 2005-07-15 2007-01-25 Kalypsys, Inc. Inhibitors of mitotic kinesin
ATE535529T1 (de) * 2005-08-09 2011-12-15 Millennium Pharm Inc Verfahren zur acylierung von maytansinol mit chiralen aminosäuren
CA2668134A1 (en) * 2006-11-06 2008-05-15 Teva Gyogyszergyar Zartkoerueen Muekoedoe Reszvenytarsasag Ascomycin and pimecrolimus having reduced levels of des-methylascomycin and 32-deoxy-32-epichloro-desmethylascomycin respectively, and methods for preparation thereof
JP2008288289A (ja) 2007-05-16 2008-11-27 Oki Electric Ind Co Ltd 電界効果トランジスタとその製造方法
JP5784592B2 (ja) 2009-06-03 2015-09-24 イミュノジェン・インコーポレーテッド 抱合方法
US8754207B2 (en) * 2009-09-25 2014-06-17 Cadila Healthcare Limited Process for the preparation of rapamycin derivatives
EP2640727B1 (en) * 2010-11-17 2015-05-13 Genentech, Inc. Alaninyl maytansinol antibody conjugates
SMT201900170T1 (it) 2012-09-26 2019-05-10 Immunogen Inc Metodo migliorato per l'acilazione di maytansinolo

Also Published As

Publication number Publication date
US9469655B2 (en) 2016-10-18
RS62075B1 (sr) 2021-07-30
DK3486248T3 (da) 2021-07-12
AU2020203823B2 (en) 2021-12-09
JP2022068367A (ja) 2022-05-09
RS58493B1 (sr) 2019-04-30
BR122021022582B1 (pt) 2023-01-10
US20170137440A1 (en) 2017-05-18
EP3904358A1 (en) 2021-11-03
US9796731B2 (en) 2017-10-24
MX366701B (es) 2019-07-22
IL253988A0 (en) 2017-10-31
PL3486248T3 (pl) 2021-10-25
HRP20211030T1 (hr) 2021-10-01
ES2716561T3 (es) 2019-06-13
MX2019008652A (es) 2019-09-13
US10944190B2 (en) 2021-03-09
AU2018201392A1 (en) 2018-03-15
CY1121415T1 (el) 2020-05-29
RU2018109295A3 (enExample) 2021-06-24
JP2020180150A (ja) 2020-11-05
TR201903625T4 (tr) 2019-04-22
EP3486248B1 (en) 2021-04-07
CN104768955B (zh) 2018-04-27
CN108586487A (zh) 2018-09-28
SI2900676T1 (sl) 2019-04-30
AU2013323572B2 (en) 2017-12-07
IL253988B (en) 2019-02-28
HUE055443T2 (hu) 2021-11-29
DK2900676T3 (en) 2019-04-08
ZA201501898B (en) 2019-06-26
JP2024010055A (ja) 2024-01-23
US10100062B2 (en) 2018-10-16
BR112015006505A2 (pt) 2017-07-04
HRP20190473T1 (hr) 2019-05-03
SI3486248T1 (sl) 2021-10-29
LT2900676T (lt) 2019-03-25
EP3486248A1 (en) 2019-05-22
AU2018201392B2 (en) 2020-03-12
AU2013323572A1 (en) 2015-04-02
CA2884873A1 (en) 2014-04-03
US20180099980A1 (en) 2018-04-12
US20250007192A1 (en) 2025-01-02
NZ706019A (en) 2018-03-23
MX2015003745A (es) 2015-06-24
BR112015006505B1 (pt) 2022-03-15
PT3486248T (pt) 2021-07-12
MY169250A (en) 2019-03-19
HUE043285T2 (hu) 2019-08-28
US20240313444A1 (en) 2024-09-19
US9012629B2 (en) 2015-04-21
RU2648992C2 (ru) 2018-03-29
WO2014052537A1 (en) 2014-04-03
HK1212341A1 (en) 2016-06-10
LT3486248T (lt) 2021-08-25
EP2900676A1 (en) 2015-08-05
PT2900676T (pt) 2019-03-29
CN108586487B (zh) 2021-11-05
US20150191488A1 (en) 2015-07-09
JP2018109044A (ja) 2018-07-12
RU2765072C2 (ru) 2022-01-25
CA3133906A1 (en) 2014-04-03
CY1124337T1 (el) 2022-07-22
AU2022201557A1 (en) 2022-03-31
CN104768955A (zh) 2015-07-08
US20140142297A1 (en) 2014-05-22
US20190013604A1 (en) 2019-01-10
PL2900676T3 (pl) 2019-06-28
JP2016500657A (ja) 2016-01-14
JP6517693B2 (ja) 2019-05-22
RU2018109295A (ru) 2019-02-26
IL237899A (en) 2017-08-31
ES2880754T3 (es) 2021-11-25
JP2020117527A (ja) 2020-08-06
SMT202100390T1 (it) 2021-09-14
US10461449B2 (en) 2019-10-29
AU2020203823A1 (en) 2020-07-02
JP6735000B1 (ja) 2020-08-05
JP2025098242A (ja) 2025-07-01
CA2884873C (en) 2021-11-23
CA3133906C (en) 2023-05-02
US20240145953A1 (en) 2024-05-02
SG11201501918UA (en) 2015-05-28
US20200153130A1 (en) 2020-05-14
RU2015111635A (ru) 2016-11-20
MX390615B (es) 2025-03-20
EP2900676B1 (en) 2018-12-19
SMT201900170T1 (it) 2019-05-10

Similar Documents

Publication Publication Date Title
HK1221472A1 (zh) 用於增加蛋白质的焦谷氨酸形成的方法
SG10201805291TA (en) Production of heterodimeric proteins
PH12013500554A1 (en) Process for preparing pan-cdk inhibitors of the formula (i) and intermediates in the preparation
WO2012025944A3 (en) Sitagliptin, salts and polymorphs thereof
SG195111A1 (en) Process for preparing methacrylic acid
PH12014502764A1 (en) Method
IN2014CN03197A (enExample)
IN2014CN04470A (enExample)
CY1124337T1 (el) Βελτιωμενες μεθοδοι για την ακυλιωση μεϋτανσινολης
EP3048172A4 (en) Method for producing l-amino acid from seaweed-derived biomass
EP3178804A4 (en) Method for producing high-efficiency methanol capable of reducing emission of carbon dioxide
MX2014014138A (es) Procedimiento nuevo para la preparacion de acido 2-ciclopentil-6-metoxi-isonicotinico.
PT3262024T (pt) Processo de produção de aminoácidos a partir de precursores obtidos por fermentação anaeróbia a partir de biomassa ermentescível
EP3098313A4 (en) Method for producing rare fatty acid using novel enzyme, and novel rare fatty acid
IL222360A0 (en) Method of vaccination
SG11201505171PA (en) Method for improving yield of enzymatic preparation of biodiesel from greases
EP3147351A4 (en) Microorganism having improved intracellular energy level and method for producing l-amino acid using same
MX2013006017A (es) Separacion de enantiomeros derivados de triazina usando acido tartarico.
MX349985B (es) Procedimiento de preparación de ésteres de fenilacetil aminoácido espirocíclicos con sustitución cis-alcoxi y derivados de 1h-pirrolidin-2,4-diona espirocicíclicos con sustitución cis-alcoxi.
WO2014008204A3 (en) Structures of proteasome inhibitors and methods for synthesizing and use thereof
MX342471B (es) Procedimiento de preparacion de un ester de acido carboxilico.
AU2013349531B2 (en) Use of an enzymatic complex in the feeding of livestock animals
MX2017003498A (es) Sal de ester metilico de fenilglicina.
MY173051A (en) Microorganism having producing ability of quinolinic acid and method for producing quinolinic acid using the microorganism
MX361888B (es) Un procedimiento mejorado para producir zilpaterol.

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 SEP 2021 BY COMPUTER PACKAGES INC

Effective date: 20200901

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 SEP 2022 BY COMPUTER PACKAGES INC

Effective date: 20210830

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 SEP 2023 BY COMPUTER PACKAGES INC

Effective date: 20220830

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 SEP 2024 BY COMPUTER PACKAGES INC

Effective date: 20230830

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 SEP 2025 BY COMPUTER PACKAGES INC

Effective date: 20240830

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 SEP 2026 BY THOMSON REUTERS

Effective date: 20250801